<DOC>
	<DOCNO>NCT02573181</DOCNO>
	<brief_summary>This study design assess safety , tolerability , immunogenicity V114 compare Prevnar 13™ healthy adult 65 year age old previously vaccinate 23-valent pneumococcal polysaccharide vaccine .</brief_summary>
	<brief_title>A Study Safety , Tolerability , Immunogenicity V114 Compared With Prevnar 13™ Healthy Adults 65 Years Age Older Previously Vaccinated With 23-valent Pneumococcal Polysaccharide Vaccine ( V114-007 )</brief_title>
	<detailed_description />
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Good health ; underlie chronic illness must document stable condition Have document proof receipt 23valent pneumococcal polysaccharide vaccine one year longer prior study entry . Male , postmenopausal female Prior administration pneumococcal vaccine 23valent pneumococcal polysaccharide vaccine History invasive pneumococcal disease know history culturepositive pneumococcal disease Known hypersensitivity vaccine component Known suspect impairment immune function Received systemic corticosteroid &gt; =14 consecutive day complete treatment &lt; =30 day prior study entry , receive systemic corticosteroid exceed physiologic replacement dos within 14 day prior study vaccination Coagulation disorder contraindicate intramuscular vaccination Receives immunosuppressive therapy , include chemotherapeutic agent use treat cancer condition , treatment associate organ bone marrow transplantation , autoimmune disease Received blood transfusion blood product , include immunoglobulin within 6 month receipt study vaccine schedule receive blood transfusion blood product within 30 day receipt study vaccine . Autologous blood transfusion consider exclusion criterion Participated another clinical study investigational product within 2 month begin time duration current clinical study User recreational illicit drug recent history ( within last year ) drug alcohol abuse dependence .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>